Retatrutide Side Effects (Preliminary Data) Common (from Phase 2 data): Nausea (25-45% depending on dose) Diarrhea (20-35%) Vomiting (10-20%) Constipation (10-15%) Decreased appetite Notable differences: Mild increases in resting heart rate observed The glucagon receptor component may introduce metabolic effects not seen with GLP-1-only medications Full safety profile awaiting Phase 3 data The overall tolerability of retatrutide in the Phase 2 trial was described as acceptable, with most adverse events being mild to moderate
Ideal for those interested in skin health, wound healing, and neurological protection
Alcohol overdose is diagnosed through a combination of clinical evaluation and laboratory testing
Functional Neurology When youve lost nerve function, our evidence-based functional neurology treatments deliver rehabilitation from noninvasive stimuli for effective results
Downstream GH Effects Once GH is released into circulation, it exerts diverse physiological effects through multiple mechanisms
Michigan Weight Loss Institute offers semaglutide (Wegovy) and tirzepatide (Zepbound) two of the most clinically proven GLP-1 weight loss medications available under the direct supervision of Dr